Novalgin and Urosepsis - a phase IV clinical study of FDA data

Summary:

Urosepsis is reported as a side effect among people who take Novalgin (metamizole), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have High blood pressure.

The phase IV clinical study analyzes which people have Urosepsis when taking Novalgin. It is created by eHealthMe based on reports of 10,087 people who have side effects when taking Novalgin from the FDA, and is updated regularly.

What is Novalgin?

Novalgin has active ingredients of metamizole. It is often used in pain. eHealthMe is studying from 10,177 Novalgin users. Check the latest studies of Novalgin.

What is Urosepsis?

Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream) is found to be associated with 893 drugs and 920 conditions by eHealthMe. Check the latest studies of Urosepsis.

On Aug, 09, 2026

10,087 people reported to have side effects when taking Novalgin.
Among them, 66 people (0.65%) have Urosepsis.

Among these 66 people:

How long have people been on Novalgin when they have Urosepsis? *

What is the gender of people who have Urosepsis when taking Novalgin? *

female: 75.44 %
male: 24.56 %

What is the age of people who have Urosepsis when taking Novalgin? *

What are other drugs people take besides Novalgin? *

What are other side effects people have besides Urosepsis? *

Urinary Tract Infection: 24 people, 36.36%
Fever: 21 people, 31.82%
General Physical Health Deterioration (weak health status): 20 people, 30.30%
Dizziness: 19 people, 28.79%
Pneumonia: 19 people, 28.79%
Anaemia (lack of blood): 17 people, 25.76%
C-Reactive Protein Increased: 15 people, 22.73%
Hypokalemia (low potassium): 14 people, 21.21%
Cardiac Failure: 14 people, 21.21%
Dehydration (dryness resulting from the removal of water): 14 people, 21.21%

What are the existing conditions these people have? *

High Blood Pressure: 16 people, 24.24%
Blood Uric Acid Increased: 14 people, 21.21%
Cardiac Failure: 14 people, 21.21%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 14 people, 21.21%
Breast Cancer: 10 people, 15.15%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 13.64%
Metastases To Bone (cancer spreads to bone): 9 people, 13.64%
Weakness: 7 people, 10.61%
Arrhythmias (irregular heartbeat): 7 people, 10.61%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 7 people, 10.61%

* Approximation only. Some reports may have incomplete information.

Do you take Novalgin and have Urosepsis?

- Check whether Urosepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novalgin:

Novalgin (10,177 reports)

Urosepsis treatments and more:

Urosepsis (11,959 reports)

Browse all side effects of Novalgin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urosepsis:

Urosepsis (893 drugs)

Browse all the conditions that are associated with Urosepsis:

Urosepsis (920 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metamizole (the active ingredients of Novalgin) and Novalgin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.